Immunosenescence refers to the gradual decline and dysfunction of the immune system that occurs naturally as people age. This process affects many components of the immune response, including the ability of immune cells to recognize and attack pathogens or abnormal…
Aging research plays a crucial and multifaceted role in the therapy of non-Hodgkin’s lymphoma (NHL), influencing how treatments are developed, tailored, and optimized, especially considering that NHL incidence and patient outcomes are closely linked to age-related factors. Understanding the biological…
Survivorship programs can significantly improve long-term outcomes for individuals with non-Hodgkin’s lymphoma by providing structured, ongoing support that addresses the complex physical, emotional, and social challenges faced after treatment. These programs focus on comprehensive follow-up care, education, symptom management, and…
Non-Hodgkin’s lymphoma (NHL) research addresses the late effects of chemotherapy by focusing on understanding, preventing, and managing the long-term health problems that survivors may face years after treatment ends. Chemotherapy, while effective at killing cancer cells, can also cause damage…
Non-Hodgkin’s lymphoma (NHL) is a complex group of blood cancers originating mainly from lymphocytes, a type of white blood cell. Monitoring the disease’s progression and response to treatment traditionally relies heavily on biopsies—procedures where tissue samples are taken from lymph…
Wearable devices are increasingly playing a transformative role in non-Hodgkin’s lymphoma (NHL) research by enabling continuous, real-time monitoring of patients’ physiological and behavioral data outside traditional clinical settings. These devices, which include sensors embedded in wristbands, patches, or clothing, provide…
Memory loss can significantly affect adherence to non-Hodgkin’s lymphoma (NHL) treatment plans because cognitive impairments interfere with a patient’s ability to remember medication schedules, appointments, and self-care instructions. This can lead to missed doses, incorrect medication use, or failure to…
Non-Hodgkin’s lymphoma (NHL) research increasingly integrates caregiver perspectives to better understand and address the full impact of the disease beyond the patient alone. Caregivers play a crucial role in the management and support of individuals with NHL, and their insights…
Non-Hodgkin’s lymphoma (NHL), particularly its aggressive subtype diffuse large B-cell lymphoma (DLBCL), remains a significant clinical challenge due to frequent relapse and resistance to conventional therapies. Recent research has increasingly focused on the tumor microenvironment (TME) — the complex ecosystem…
Immune profiling plays a crucial and transformative role in the precision care of non-Hodgkin’s lymphoma (NHL) by providing detailed insights into the tumor’s immune environment, guiding personalized treatment strategies, and improving patient outcomes. At its core, immune profiling involves analyzing…